SPI vs. ONT, GNS, CRW, UPR, PRTC, AMS, MXCT, BMK, OXB, and NIOX
Should you be buying Spire Healthcare Group stock or one of its competitors? The main competitors of Spire Healthcare Group include Oxford Nanopore Technologies (ONT), Genus (GNS), Craneware (CRW), Uniphar (UPR), PureTech Health (PRTC), Advanced Medical Solutions Group (AMS), MaxCyte (MXCT), Benchmark (BMK), Oxford Biomedica (OXB), and NIOX Group (NIOX). These companies are all part of the "medical" sector.
Oxford Nanopore Technologies (LON:ONT) and Spire Healthcare Group (LON:SPI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, valuation, profitability, institutional ownership, media sentiment, earnings, risk and analyst recommendations.
In the previous week, Oxford Nanopore Technologies had 1 more articles in the media than Spire Healthcare Group. MarketBeat recorded 3 mentions for Oxford Nanopore Technologies and 2 mentions for Spire Healthcare Group. Spire Healthcare Group's average media sentiment score of 1.51 beat Oxford Nanopore Technologies' score of 0.29 indicating that Oxford Nanopore Technologies is being referred to more favorably in the media.
Spire Healthcare Group received 327 more outperform votes than Oxford Nanopore Technologies when rated by MarketBeat users. However, 100.00% of users gave Oxford Nanopore Technologies an outperform vote while only 60.82% of users gave Spire Healthcare Group an outperform vote.
Spire Healthcare Group has a net margin of 2.01% compared to Spire Healthcare Group's net margin of -91.06%. Oxford Nanopore Technologies' return on equity of 3.81% beat Spire Healthcare Group's return on equity.
38.6% of Oxford Nanopore Technologies shares are held by institutional investors. Comparatively, 45.1% of Spire Healthcare Group shares are held by institutional investors. 30.0% of Oxford Nanopore Technologies shares are held by company insiders. Comparatively, 34.7% of Spire Healthcare Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Spire Healthcare Group has higher revenue and earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.
Oxford Nanopore Technologies has a beta of 0.64, indicating that its share price is 36% less volatile than the S&P 500. Comparatively, Spire Healthcare Group has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500.
Oxford Nanopore Technologies presently has a consensus price target of GBX 303.75, indicating a potential upside of 177.65%. Spire Healthcare Group has a consensus price target of GBX 302.25, indicating a potential upside of 16.25%. Given Spire Healthcare Group's higher probable upside, equities research analysts plainly believe Oxford Nanopore Technologies is more favorable than Spire Healthcare Group.
Summary
Spire Healthcare Group beats Oxford Nanopore Technologies on 11 of the 17 factors compared between the two stocks.
Get Spire Healthcare Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for SPI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SPI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Spire Healthcare Group Competitors List
Related Companies and Tools
